Zachariah Serber, Chief Science Officer at Zymergen Inc. (ZY), sold 43,460 shares at $4.76 ($207K) on 2022-01-24, disclosed to the SEC on 2022-01-26.
Open-market sale of $207k ZY by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.76 | 21,730 | $103K | 50.0% |
| 2 | $4.76 | 21,730 | $103K | 50.0% |
| Total | $4.76 avg | 43,460 | $207K | 100% |
| Filing → |
| ZY | SELL | 2022-08-04 | $8K | — | Filing → |
| ZY | SELL | 2022-07-07 | $4K | — | Filing → |
| ZY | SELL | 2022-06-06 | $5K | — | Filing → |